November 17, 2026 at 09:42 PM UTC
Protagenic Therapeutics, Inc.\new reports material agreement in SEC 8-K
Protagenic Therapeutics, Inc.\new filed an 8-K covering a material definitive agreement, an unregistered sale of equity securities, and a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 17, 2026 at 09:41 PM UTC
Open official source